Product Information
AZITHROMYCIN 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5409 per EA under NDC 50111078810. Its NADAC has been published 472 times since Aug 30, 2017.
FDA first approved this application on Nov 14, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111078810
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065223FDA Approved
11/14/2005
TE Code
AB
On Market Since
1/6/2006
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 500 MG TABLET has been published 472 times since Aug 30, 2017, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5409 per EA |
|---|---|
| All-time high | $1.6988 (Jun 13, 2018) |
| All-time low | $0.5197 (Nov 20, 2024) |
| 52-week high | $0.6589 |
| 52-week low | $0.5409 |
| Median price | $0.8209 |
| Average price | $0.9605 |
| Largest weekly change | -24.1% (Nov 20, 2024) |
| Weeks tracked | 472 |
| Tracking since | Aug 30, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Azithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.5409 per EA (NDC 50111078810), effective Sep 30, 2026.
How has the price of AZITHROMYCIN 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 500 MG TABLET has declined 57.7%. It has been tracked across 472 weekly CMS publications since Aug 30, 2017.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 500 MG TABLET?
Since Aug 30, 2017, the NADAC for AZITHROMYCIN 500 MG TABLET has ranged from a low of $0.5197 (Nov 20, 2024) to a high of $1.6988 (Jun 13, 2018), with a median of $0.8209 per EA.
Are there cheaper alternatives to AZITHROMYCIN 500 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AZITHROMYCIN 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AZITHROMYCIN 500 MG TABLET?
AZITHROMYCIN 500 MG TABLET (NDC 50111078810) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.